These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6244309)

  • 1. Irreversible photoactivation of a pancreatic secretagogue receptor with cholecystokinin COOH-terminal octapeptides.
    Galardy RE; Hull BE; Jamieson JD
    J Biol Chem; 1980 Apr; 255(7):3148-55. PubMed ID: 6244309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
    Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
    J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
    Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
    J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two functionally distinct cholecystokinin receptors show different modes of action on Ca2+ mobilization and phospholipid hydrolysis in isolated rat pancreatic acini. Studies using a new cholecystokinin analog, JMV-180.
    Matozaki T; Göke B; Tsunoda Y; Rodriguez M; Martinez J; Williams JA
    J Biol Chem; 1990 Apr; 265(11):6247-54. PubMed ID: 1690723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic cholecystokinin analogues with high selectivity for central receptors.
    Charpentier B; Pelaprat D; Durieux C; Dor A; Reibaud M; Blanchard JC; Roques BP
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1968-72. PubMed ID: 3162318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional cholecystokinin receptors are distinguished kinetically by biotinyl-Tyr-Gly-(Thr28,Nle31)CCK(25-33) in rat pancreatic acini.
    Winand J; Poloczek P; Delporte C; Moroder L; Svoboda M; Christophe J
    Biochim Biophys Acta; 1991 Oct; 1080(2):181-90. PubMed ID: 1718434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD; Knight M; Sutliff VE; Jensen RT
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of binding of cholecystokinin to pancreatic acini.
    Wank SA; Jensen RT; Gardner JD
    Am J Physiol; 1988 Jul; 255(1 Pt 1):G106-12. PubMed ID: 3389410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Products of cholecystokinin (CCK)-octapeptide proteolysis interact with central CCK receptors.
    Steardo L; Knight M; Tamminga CA; Chase TN
    Neurosci Lett; 1985 Mar; 54(2-3):319-25. PubMed ID: 2986058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic peptide derivative that is a cholecystokinin receptor antagonist.
    Lignon MF; Galas MC; Rodriguez M; Laur J; Aumelas A; Martinez J
    J Biol Chem; 1987 May; 262(15):7226-31. PubMed ID: 2438274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists.
    Spanarkel M; Martinez J; Briet C; Jensen RT; Gardner JD
    J Biol Chem; 1983 Jun; 258(11):6746-9. PubMed ID: 6304053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatum.
    Mendre C; Rodriquez M; Gueudet C; Lignon MF; Galas MC; Laur J; Worms P; Martinez J
    J Biol Chem; 1988 Aug; 263(22):10641-5. PubMed ID: 3392031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the behavioral activity of C- and N-terminal fragments of cholecystokinin octapeptide.
    Crawley JN; St-Pierre S; Gaudreau P
    J Pharmacol Exp Ther; 1984 Aug; 230(2):438-44. PubMed ID: 6086888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of a probe for the cholecystokinin octapeptide receptor, N alpha (125I-desaminotyrosyl)CCK-8, and its interactions with pancreatic acini.
    Miller LJ; Rosenzweig SA; Jamieson JD
    J Biol Chem; 1981 Dec; 256(23):12417-23. PubMed ID: 6271785
    [No Abstract]   [Full Text] [Related]  

  • 16. Discovery of a cholecystokinin analogue with partial agonist activity.
    Howard JM; Knight M; Jensen RT; Gardner JD
    Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
    J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin peptides stimulate pancreatic secretion by multiple signal transduction pathways.
    Yoshida H; Tsunoda Y; Owyang C
    Am J Physiol; 1997 Sep; 273(3 Pt 1):G735-47. PubMed ID: 9316479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and some pharmacological properties of Z-Tyr(SO3H)-Met-Gly-Trp-Met-Asp(Phe-NH2)-OH, a 32-beta-aspartyl analogue of cholecystokinin (pancreozymin) 27-33.
    Martinez J; Winternitz F; Bodanszky M; Gardner JD; Walker MD; Mutt V
    J Med Chem; 1982 May; 25(5):589-93. PubMed ID: 6177857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
    Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
    Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.